Home / Shipping / Aviation/ Cathay Pacific joins Pharma.Aero

Cathay Pacific joins Pharma.Aero


Comments / {{hitsCtrl.values.hits}} Views / Monday, 22 April 2019 00:00

Facebook

Cathay Pacific has become a full member of Pharma.Aero, a cross-industry collaboration for pharma shippers, CEIV-certified cargo communities, airport operators and other air cargo industry stakeholders.  Cathay Pacific has been CEIV Pharma certified since October 2017. 

Pharma.Aero, whose aim is to achieve excellence in the reliable, end-to-end air transportation and handling of high-value, time-sensitive pharmaceutical products, announced Cathay Pacific’s membership today at the IATA World Cargo Symposium in Singapore.

Cathay Pacific Regional Head of Cargo for South Asia, Middle East and Africa Rajesh Menon said: “India and Bangladesh are both big markets for Cathay Pacific, especially when it comes to shipments of pharmaceutical products. Hyderabad, Bangalore and Mumbai followed by Dhaka have always had large number of pharma shipments and this continues to grow. United States, Canada and Australia are key trade lanes for India and Bangladesh. PharmaLIFT is an important product and our handling expertise is a key USP we provide to our agents. Collaborating with Pharma.Aero, this offering will only become stronger to provide quality in the transportation and expert handling of valuable and sensitive pharmaceutical products” 

Pharmaceutical shipments travelling the corridor will be handled in strict compliance with the IATA’s CEIV Pharma standard. Shippers will be assured of seamless airport-to-airport (A2A) temperature-controlled handling, assuring the integrity of the shipments. 

Pharma.Aero Chairman Nathan De Valck added: “We are excited about Cathay Pacific joining our collaboration group as a full member. Their active involvement in the pilot of the pharma corridor project is a clear added value. In collaboration with Pharma.Aero and our pharma shipper members, key performance indicators of the pharma corridor will be clearly defined, targeting to set A2A pharma handling standards.”


Share This Article

Facebook Twitter


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Revitalising the tourist inflows

Wednesday, 22 May 2019

Easter Sunday 21 April terror acts have dealt a very heavy blow on tourism. The inflow has dried up for the moment while it can be presumed that forward selling too may have become sluggish. It is noted that Government has introduced a series of meas


Truth has now arrived, and falsehood has perished

Wednesday, 22 May 2019

“And say: Truth has now arrived, and Falsehood has perished: for Falsehood by its very own nature is bound to perish.” Holy Quran: Chapter 17 Verse 81. Every discussion, debate and discourse that we see and hear over the audio – visual and prin


Afghan refugees face Jaffna’s hostility: These Sri Lankans are crazy

Wednesday, 22 May 2019

Abbas Ahmadi, an IT specialist, was rather high in the Afghan provincial civil service. He is of Hazara ethnicity and persecuted by the majority Pashtuns who ironically dominate the ruling faction as well as the rebelling Taliban.The Hazaras are inpa


One month gone: No charge on over 200 Catholics murdered

Wednesday, 22 May 2019

It’s been one month since the murder of around 300 innocent Catholic children and parents but no has yet been charged for the biggest negligence of duty that Sri Lanka has seen in recent history. The President and Prime Minister have both denied a


Columnists More